Among patients with renal cell carcinoma, those with larger tumors may yield the most benefit from SBRT compared with other ...

Compared with other ablative therapies, stereotactic body radiotherapy might offer a ‘particularly advantageous option’ for ...

Dr. Alan Tan explores circulating tumor DNA, its role in clinical trials and its potential impact on patients with renal cell ...

A Duluth teenager with terminal cancer celebrated her birthday and high school graduation early this month with a ...

An expert discusses how third line (3L) systemic therapy for metastatic renal cell carcinoma (mRCC) is guided by prior ...

SESAUA annual meeting featured a kidney cancer session and a presentation by Dr. Robert Smith discussing how age and tumor ...

The following is a summary of “Metabolic syndrome and increased susceptibility to renal cell carcinoma – a meta-analysis,” ...

A personalized vaccine demonstrated the potential to induce long-lasting immune response among people with advanced kidney ...

A clinical trial demonstrates that personalised cancer vaccines effectively target mutations in high-risk kidney cancer, ...

Burchfield, MD, and other participants discussed their experiences with the frontline combination regimens for advanced renal ...